Werner Milton H.
SEC insider (Form 3/4/5 filer). CIK 0001827621. President and CEO at Inhibikase Therapeutics, Inc. (IKT). 21 reported Form 4/5 transactions since Sep 2024; latest on Jan 21, 2025. Located in ATLANTA, GA.
Companies Werner Milton H. has filed insider reports for
- Inhibikase Therapeutics, Inc. (IKT): Director, Officer, President and CEO
Werner Milton H.
CIK: 0001827621
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Inhibikase Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.6K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
3.6K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.6K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
3.6K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.6K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
3.6K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.6K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
3.6K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.6K shares- - Jan 21, 2025IKT
Inhibikase Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
3.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,643 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 3,643 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,643 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 3,643 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,643 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 3,643 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,643 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 3,643 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,643 | - | - | Direct |
| Jan 21, 2025 | IKT Inhibikase Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 3,643 | - | - | Direct |
1-10 of 21 transactions